Recently, Chen ES and colleagues proposed SAA as a key regulator of granulomatous inflammation in Sarcoidosis[14], hence, any new study should also include non-sarcoid inflammatory lung diseases as comparator groups. This evidence concerns the gene SAA2 and sarcoidosis.